Loading…
Based on limited metadata, Royal Philips received an FDA Warning Letter on February 23, 2024, regarding medical devices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning letter indicates regulatory concerns significant enough to warrant formal FDA enforcement action against this major medical device manufacturer. Further review of the complete warning letter would be necessary to identify the specific compliance issues and affected product lines.